tm logo
H.F.M STEM CELLS
Live/Registered
REGISTERED

on 04 Apr 2023

Last Applicant/ Owned by

69120 Heidelberg

DE

Serial Number

79311220 filed on 21st Dec 2020

Registration Number

7014490 registered on 04th Apr 2023

in the Principal Register

Correspondent Address

Sean K. Owens

Sean K. Owens

441 VINE STREET, Suite 2700

CINCINNATI OH 45202

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

H.F.M STEM CELLS

Stem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes; medical research; research and development of new products for o Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services relating to the removal, treatment, processing and preservation of human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells

Class [042]
Computer & Software Services & Scientific Services


Stem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research, namely, technical writing for others; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; development of industrial processes, namely, engineering of industrial processes in the field of for packaging, storage and transport of human tissue and human adult ancestral cells, engineering of industrial processes to manufacture stem cells; industrial process research in the field of regenerative medicine and tissue engineering, chemical engineering

Class [005]
Pharmaceutical Products


pharmaceutical drugs, namely pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, and wound healing; pharmaceutical preparations for anti-aging; pharmaceutical preparations namely antibiotics; diagnostic agents for medical use; preparations for medical purposes, namely, for the treatment of skin diseases; substances for medical use, namely, for regeneration of tissue and anti-inflammation; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes, namely, for anti-aging, for use in dermatology procedures; somatic stem cell therapeutics, namely, for medical therapeutic use; fibroblasts for medical use; fibroblasts for aesthetic purposes, namely, for use in dermatology procedures; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical for treatment of skin diseases, blood diseases, vertigo, nausea, vomiting, migraine, respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; surgical implants derived from stem cells, namely, surgical implants derived from living tissues and living stem cells; surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; biological tissue for implantation, namely, implants comprising living tissues; cell growth media for growing cells for medical use; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue, namely, surgical implants comprised of living tissues; biotechnologically engineered tissue products, namely, living tissue cell sheets and plasters for wound healing and burns, biological eye lens grafts, bone grafts in the nature of biological bone tissue for grafting, biological tissue grafts, human allograft tissue

Class [001]
Chemical Products


Stem cells for scientific or research use; cell growth media for growing cells for scientific use

Mark Details


Serial Number

No 79311220

Mark Type

No Service Mark

Attorney Docket Number

No MREC-3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Jul 2023FINAL DISPOSITION PROCESSED
20th Jul 2023FINAL DISPOSITION NOTICE SENT TO IB
04th Jul 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04th Apr 2023REGISTERED-PRINCIPAL REGISTER
04th Apr 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
24th Jan 2023NOTIFICATION PROCESSED BY IB
17th Jan 2023PUBLISHED FOR OPPOSITION
17th Jan 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04th Jan 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04th Jan 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB